English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Acute undifferentiated leukemia (AUL) is a rare subset of acute leukemias, being included in the 2008 edition of the World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues as a special category called ʻacute leukemias of ambiguous lineageʼ, in which the leukemic cells express no more than one membrane marker of any given lineage. We report a rare case of therapy-related acute myeloid leukemia (AML), in which a strict myeloid marker myeloperoxidase (MPO) expression was confirmed by real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis but not immunophenotyping. Although the diagnosis of AUL was initially considered, the lineage of leukemic cells was demonstrated by qRT-PCR analysis. Our observations suggest that molecular analysis of lineage markers may help to establish the diagnosis of acute leukemias.

Acute Undifferentiated Leukemia or Minimally Differentiated Acute Myeloid Leukemia: Further Emphasis on Molecular Analysis in Leukemia Diagnosis